Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W To

Showing results (11-20 of 285) with videos related to

Pageof 29
Sort By:
Cellular and Molecular Life Sciences : CMLS|May 16, 2019
Drug repurposing to overcome resistance to various therapies for colorectal cancerWinnie Fong, Kenneth K W To
Journal of Thoracic Disease|February 2, 2012
The Management of the 2009 pandemic Influenza A H1N1 virus infectionKelvin K W To, Kwok-Yung Yuen
Investigational New Drugs|August 19, 2017
CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistanceKenneth K W To, Li-Wu Fu
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
An efficient way of studying protein-protein interactions involving HIF-α, c-Myc, and Sp1Kenneth K-W To, L Eric Huang
The Journal of Biological Chemistry|September 15, 2005
Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1Kenneth K W To, L Eric Huang
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 12, 2020
Responding to COVID-19 in Hong KongK K W To, K Y Yuen
Pharmaceutics|August 26, 2023
Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer ImmunotherapyKenneth K W To, William C Cho
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 25, 2026
Cholera outbreak in 1932 and a public education pamphlet on the prevention of choleraD C Lung, K K W To
Current Cancer Drug Targets|February 4, 2021
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple MechanismsKenneth K W To, William C S Cho
Current Cancer Drug Targets|March 8, 2022
Mesenchymal Epithelial Transition (MET): A Key Player in Chemotherapy Resistance and an Emerging Target for Potentiating Cancer ImmunotherapyKenneth K W To, William C S Cho
Pageof 29

Showing results (11-20 of 285) with videos related to

Sort By:
Pageof 29
Cellular and Molecular Life Sciences : CMLS|May 16, 2019
Drug repurposing to overcome resistance to various therapies for colorectal cancerWinnie Fong, Kenneth K W To
Journal of Thoracic Disease|February 2, 2012
The Management of the 2009 pandemic Influenza A H1N1 virus infectionKelvin K W To, Kwok-Yung Yuen
Investigational New Drugs|August 19, 2017
CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistanceKenneth K W To, Li-Wu Fu
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
An efficient way of studying protein-protein interactions involving HIF-α, c-Myc, and Sp1Kenneth K-W To, L Eric Huang
The Journal of Biological Chemistry|September 15, 2005
Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1Kenneth K W To, L Eric Huang
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 12, 2020
Responding to COVID-19 in Hong KongK K W To, K Y Yuen
Pharmaceutics|August 26, 2023
Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer ImmunotherapyKenneth K W To, William C Cho
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 25, 2026
Cholera outbreak in 1932 and a public education pamphlet on the prevention of choleraD C Lung, K K W To
Current Cancer Drug Targets|February 4, 2021
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple MechanismsKenneth K W To, William C S Cho
Current Cancer Drug Targets|March 8, 2022
Mesenchymal Epithelial Transition (MET): A Key Player in Chemotherapy Resistance and an Emerging Target for Potentiating Cancer ImmunotherapyKenneth K W To, William C S Cho
Pageof 29